Nearly four thousand researchers attending a Vancouver conference on Alzheimer's disease have released promising results for people in the early stages of memory loss. A three-year study involving immunotherapy called I-V-I-G (intravenus immunoglobulin) has produced evidence of no decline in patients since they developed signs of Alzheimer's, … [Read more...]